✦ LIBER ✦

The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients

✍ Scribed by Alessandra Sacchi; Chiara Agrati; Gianpiero D'Offizi; Chrysoula Vlassi; Gabriella Rozera; Isabella Abbate; Maria Rosaria Capobianchi; Federico Martini

Book ID: 113541908
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 751 KB
Volume: 138
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2010.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

890 ACTIVATION OF INNATE IMMUNITY CELLS

890 ACTIVATION OF INNATE IMMUNITY CELLS MAY PREDICT EARLY HCV TREATMENT OUTCOME IN HIV/HCV CO-INFECTED PATIENTS

✍ A. Sacchi; E. Lalle; C. Vlassi; A. Vitali; G. D'Offizi; F. Martini; I. Abbate; G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Hepatic steatosis in HIV/HCV co-infected

Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study

✍ Maribel Rodríguez-Torres; Sugantha Govindarajan; Ricard Solá; Nathan Clumeck; Ed 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 422 KB

825 RESULTS OF A RANDOMIZED CONTROLLED T

825 RESULTS OF A RANDOMIZED CONTROLLED TRIAL ON THE IMPACT OF PROLONGED COMBINATION ANTI-HCV TREATMENT IN HIV/HCV CO-INFECTED PATIENTS

✍ M. Puoti; B. Zanini; A. De Luca; G.P. Quinzan; R. Allegri; R. Bruno; A. Orani; T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

625 RISK FACTORS FOR HEPATOTOXICITY OF A

625 RISK FACTORS FOR HEPATOTOXICITY OF ARV IN HIV/HCV CO-INFECTED PATIENTS WITH A 6 YEARS FOLLOW-UP AFTER A COMPLETION OF A FULL COURSE ANTI-HCV TREATMENT

✍ E. Krastinova; F. Bani-Sadr; S. Pol; P. Cacoub; E. Rosenthal; C. Perronne; F. Ca 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 120 KB

507 Early prediction of sustained virolo

507 Early prediction of sustained virological response (SVR) during treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (RBV) (COPEGUS®) in patients with HCV/HIV co-infection: Results from the aids pegasys ribavirin international co-infectio (abstract withdrawn)

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Interferon-α 2b treatment of chronic act

Interferon-α 2b treatment of chronic active hepatitis C in patients co-infected with the human immunodeficiency virus (HIV): HCV viremia quantified by B-DNA and genotypic analysis 1111221. Dept. of Gastroenterology1 and Hematology2, Hospital Geral de Santo António, Oporto, Portugal

📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB